Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Bolt Biotherapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −2 vs. Q1 2024
- Shares held
- 22.6M
- −1.38M (−5.7%) vs. Q1 2024
- Total value
- $17.0M
- −$16.6M (−49.5%) vs. Q1 2024
- New holders
- 4
- 13 more added
- Sold out
- 6
- 6 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BOLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $2.31M |
| Q1 2026 | 24 | $2.49M |
| Q4 2025 | 21 | $3.30M |
| Q3 2025 | 24 | $4.28M |
| Q2 2025 | 25 | $5.10M |
| Q1 2025 | 30 | $7.33M |
| Q4 2024 | 38 | $9.99M |
| Q3 2024 | 32 | $12.2M |
| Q2 2024 | 37 | $17.0M |
| Q1 2024 | 39 | $33.6M |
| Q4 2023 | 40 | $27.0M |
| Q3 2023 | 35 | $25.5M |
| Q2 2023 | 40 | $32.1M |
| Q1 2023 | 41 | $32.4M |
| Q4 2022 | 44 | $26.8M |
| Q3 2022 | 56 | $39.7M |
| Q2 2022 | 62 | $54.8M |
| Q1 2022 | 66 | $79.3M |
| Q4 2021 | 62 | $164.6M |
| Q3 2021 | 72 | $449.1M |
| Q2 2021 | 61 | $513.8M |
| Q1 2021 | 70 | $1.04B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Bolt Biotherapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tang Capital Management LLC | 3,812,773 | $2.86M | 0.29% | +392,773+11.5% | Added |
| Vivo Capital, LLC | 3,521,291 | $2.64M | 0.24% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 2,754,437 | $2.07M | 0.13% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,367,511 | $1.78M | 0.00% | −48,217−2.0% | Reduced |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $1.42M | 1.09% | 00.0% | Unchanged |
| Newtyn Management, LLC | 1,363,234 | $1.02M | 0.19% | −336,766−19.8% | Reduced |
| Nan Fung Group Holdings Ltd | 1,166,952 | $875.2K | 0.93% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,067,405 | $800.6K | 0.00% | +29,802+2.9% | Added |
| Samsara BioCapital, LLC | 1,049,153 | $786.9K | 0.16% | 00.0% | Unchanged |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $539.7K | 0.04% | 00.0% | Unchanged |
| Acuitas Investments, LLC | 630,507 | $472.9K | 0.25% | +112,555+21.7% | Added |
| Adage Capital Partners GP, L.L.C. | 500,000 | $375.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 370,790 | $278.1K | 0.00% | +23,223+6.7% | Added |
| Renaissance Technologies LLC | 276,739 | $207.6K | 0.00% | −240,898−46.5% | Reduced |
| BlackRock Inc. | 267,068 | $200.3K | 0.00% | +12,110+4.7% | Added |
| ADAR1 Capital Management, LLC | 185,999 | $139.5K | 0.03% | +180,999+3,620.0% | Added |
| Marquette Asset Management, LLC | 113,797 | $85.3K | 0.01% | +17,124+17.7% | Added |
| FMR LLC | 86,613 | $65.0K | 0.00% | +7,714+9.8% | Added |
| Bridgeway Capital Management, LLC | 85,200 | $63.9K | 0.00% | −26,000−23.4% | Reduced |
| Prudential Financial Inc | 54,400 | $40.8K | 0.00% | +19,200+54.5% | Added |
| Two Sigma Securities, LLC | 53,886 | $40.4K | 0.00% | +30,072+126.3% | Added |
| UBS Group AG | 48,825 | $36.6K | 0.00% | +36,654+301.2% | Added |
| State Street Corp | 47,437 | $35.6K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 41,528 | $31.1K | 0.00% | +41,528 | New |
| Northern Trust Corp | 40,895 | $30.7K | 0.00% | −110−0.3% | Reduced |
| Assenagon Asset Management S.A. | 34,488 | $25.9K | 0.00% | +34,488 | New |
| Morgan Stanley | 33,687 | $25.3K | 0.00% | +9,000+36.5% | Added |
| Susquehanna International Group, LLP | 22,410 | $16.8K | 0.00% | +22,410 | New |
| Advisor Group Holdings, Inc. | 15,000 | $11.3K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 1,000 | $750 | 0.00% | +1,000 | New |
| JPMorgan Chase & Co | 840 | $630 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 628 | $471 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 184 | $138 | 0.00% | −5,362−96.7% | Reduced |
| Barclays PLC | 139 | $104 | 0.00% | 00.0% | Unchanged |
| Salem Investment Counselors Inc | 40 | $30 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 358 | $0 | 0.00% | +357+35,700.0% | Added |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −1,541,000−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −78,020−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −45,956−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −12,826−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,938−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −211−100.0% | Sold out |